Eagle Pharmaceuticals Inc
NASDAQ:EGRX
| Market Cap (Intraday) | 563.15M |
| Current PE | 114.07 |
| Forward PE | 12.86 |
| 2yr Forward PE | 10.12 |
| 10-Day MA | $43.53 |
| 50-Day MA | $47.34 |
| 200-Day MA | $46.23 |
Eagle Pharmaceuticals, Inc. Stock, NASDAQ:EGRX
50 Tice Boulevard, Suite 315, Woodcliff Lake, New Jersey 07677-9991
United States of America
Phone: +1.201.326.5300
Number of Employees: 108
Description
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.